key: cord-0885974-c1acmz8j
authors: Ilias, Ioannis; Zabuliene, Lina
title: Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms
date: 2020-06-30
journal: Medical Hypotheses
DOI: 10.1016/j.mehy.2020.109699
sha: bfbbf04feedacf1117e45338a1f2cde879f17275
doc_id: 885974
cord_uid: c1acmz8j

nan

Acutely ill patients present often with hyperglycemia (caused among other factors by endogenous stress-induced glucocorticoid hypersecretion) [1] . In preliminary reports, presenting clinical characteristics of patients with the novel Covid-19 infection, hyperglycemia was noted in 51% of cases [2] . Interestingly, transient hyperglycemia was also noted in patients with SARS (Severe Acute Respiratory Syndrome in 2003, caused by another coronavirus, closely related to Covid-19, SARS-CoV) [3] ; the virus leads to transient impairment of pancreatic islet cell function [3] . Additionally, the also closely related, Middle Eastern Respiratory Syndrome (MERS in 2013) coronavirus (MERS-CoV) as well as human coronavirus-EMC are anchored to host cells via dipeptidyl peptidase 4 (DPP-4, which physiologically is implicated in the modulation of insulin action and as an enzyme plays a major role in glucose metabolism and is responsible for the degradation of incretins such as glucagon like peptide −1, GLP-1) [4, 5] . Thus, we believe that the hyperglycemia noted in patients with Covid-19 may be caused via such (or analogous) mechanisms; this remains to be assessed by ulterior studies. Nevertheless, the issue of hyperglycemia should not be overlooked, since it may lead to additional immune suppression and further complications [6] .

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Stress hyperglycemia: an essential survival response!

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes

Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Relationship between hyperglycemia and infection in critically ill patients